Midazolam sedation in endoscopy
Phase 3
- Conditions
- pper endoscopy.Upper endoscopy for evaluation of upper GI diseases
- Registration Number
- IRCT201110087740N1
- Lead Sponsor
- Ahvaz University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Inclusion criterion: patients aged between 20 to 60 years old candidate for upper endoscopy.
Exclusion criteria:GIB; COPD; CHF and intolerance to upper endoscopy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Midazolam sedation for making upper endoscopy more comfort. Timepoint: 2 hours after intervention. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method Amnesia after endoscopy. Timepoint: 2 hours after endoscoy. Method of measurement: Questionnaire.